Researchers bend DNA strands with light, revealing a new way to study the genome
On Sep. 9, 2024, a Princeton University team announced they had developed a way to probe chromosomes and…
-
-
CSL’s Novel Gene Therapy HEMGENIX® (etranacogene dezaparvovec-drlb) Demonstrated Durable Protection and Sustained Factor IX Activity Levels for People Living with Hemophilia B
On Dec. 10, 2022, CSL announced data affirming the long-term durability and safety of single-infusion HEMGENIX® (etranacogene dezaparvovec-drlb)…
-
Seqirus began shipping 2020/21 influenza vaccines to U.S. market
On Jul. 30, 2020, Seqirus announced it had begun shipping its portfolio of seasonal influenza vaccines to customers…
-
New virus detection process under development at Rutgers-Camden
On Apr. 21, 2020,the fight against the coronavirus is underway in a Rutgers UniversityﾖCamden research laboratory, where chemistry…
-
Pluristem treated first COVID-19 patient in US under FDA single patient expanded access program
On Apr. 13, 2020, Pluristem Therapeutics announced it has treated its first patient suffering from COVID-19 complications in…
-
FDA approved Fluad Quadrivalent (influenza vaccine, adjuvanted; Seqirus) for adults 65 years and older
On Feb. 24, 2020, Seqirus announced that the U.S. Food and Drug Administration (FDA) had approved the first…
-
Sorrento and Celularity to initiate emergency allogeneic natural killer cell therapy development for Coronavirus infection
On Jan. 29, 2020, Sorrento Therapeutics announced it had initiated a clinical and manufacturing collaboration with Celularity, a…
-
Seqirus’ Received Health Canada approval of first cell-based seasonal influenza vaccine
On Dec. 11, 2019, Seqirus announced that its cell-based quadrivalent influenza vaccine (QIVc) had received approval from Health…
-
Seqirus’ Next Generation Cell-based Influenza Vaccine Shows Significantly Greater Effectiveness Compared to Standard Egg-based Options in the 2017-18 US Influenza Season
On Dec. 5, 2018, Seqirus, a CSL subsidiary, announced real-world data showing that its cell-based quadrivalent influenza vaccine…
-
Teva Pharmaceuticals announced North America headquarters moved to New Jersey
On Jul. 6, 2018, Teva Pharmaceuticals announced it would move its U.S. headquarters to Parsippany-Troy Hills, New Jersey…
-
The Lombardi Comprehensive Cancer Center became the 16th National Cancer Institute-designated Comprehensive Cancer Center
In 2018, the Lombardi Comprehensive Cancer Center became the 16th National Cancer Institute-designated Comprehensive Cancer Center funded with…
-
The Omar Boraie Chair in Genomic Science was established at Rutgers Cancer Institute
On Oct. 21, 2015, the Omar Boraie Chair in Genomic Science was established at Rutgers Cancer Institute. The…
-
Stephen J Elledge and Evelyn M Witkin received Lasker Award
On Sept. 18, 2015, Stephen J. Elledge from Brigham and Women’s Hospital and Evelyn M. Witkin from Rutgers…
-
Juno Theraputics completed its IPO
On Dec. 23, 2014, Juno Therapeutics announced the closing of its initial public offering of 12.7 million shares…
-
Bristol-Myers Squibb announced plans to build state-of-the-art campus in Lawrenceville
On Sept. 23, 2014, Bristol-Myers Squibb announced plans to build a 650,000-square-foot office building on company-owned land in…
-
The Tisch Cancer Institute was founded in New York
In 2008, the Tisch Cancer Institute (TCI) was founded through the generosity of James and Merryl Tisch. James…
-
FDA approved lowering the age limit to 12 mos for one of the two licensed hepatitis A vaccine
On Aug. 11, 2005, the Food and Drug Administration (FDA) approved an application of a pediatric/adolescent formulation of…
-
Scientists Create Smart Mouse
On Sept. 1, 1999, Princeton University researchers reported that they had genetically modified mice to have improved learning…
-
Bristol-Myers Squibb opened a 433-acre research campus in Hopewell, New Jersey
In 1997, Bristol-Myers Squibb opened a 433-acre research campus in Hopewell, New Jersey. Two important new medicines co-developed…
-
Biotechnology Council of New Jersey was founded
In 1994, The Biotechnology Council of New Jersey (BCNJ) was founded. Today, BioNJ is the life sciences trade…
-
The Rutgers Cancer Institute of New Jersey was established at Rutgers University in New Brunswick
In 1991, the Rutgers Cancer Institute of New Jersey was established at Rutgers, the State University of New…
-
Ohio University received patent on gene-transfer
On Oct. 10, 1989, Ohio University (OU) announced that it had received a patent for a genetic engineering…
-
Merck Frosst Canada was established
In 1982, Merck Frosst Canada was created through the restructuring of Merck & Co., Charles E. Frosst, and…
-
The most mutated gene in human cancer, p53, a tumor suppressor gene, was identified
In 1979, the most frequently mutated gene in human cancer, p53, was identified by six groups of researchers…
-
Johnsonﾠ &ﾠ Johnson announced plans to build new World Headquarters in New Brunswick, New Jersey
In 1978, Johnsonﾠ & ﾠJohnson announced plans to build their new World Headquarters in New Brunswick, New Jersey….
-
swine flu vaccination program in the U.S. Suspended following reports of paralysis
On Oct. 13, 1976, the swine flu vaccination program in the U.S. was suspended following reports of paralysis. …
-
Biotechnology | CDC | Diagnostics | FDA | Influenza | Life Science History | Therapeutics | Vaccine
H1N1 outbreak at Fort Dix lead to a vaccination program to prevent a pandemic
In 1976, Influenza A/Victoria-like strains had been identified in New Jersey as early as January 21. The novel…
-
Squibb established worldwide headquarters in Princeton, New Jersey
In 1971, Squibb established worldwide headquarters in Princeton, New Jersey. It also expanded facilities for the Squibb Institute…
-
The Priestley Medal was awarded to William Oliver Baker
In 1966, the American Chemical Society awarded the Priestley Medal to William Oliver Baker “to recognize distinguished services…
-
Merck & Co acquired Charles E Frosst & Co
In 1965, Merck & Co. of New Jersey acquired Charles E. Frosst. In 1968, Merck Frosst Laboratories was…
